By ecancer reporter Janet Fricker Many reports of cancer drug trials use general or subjective terms to describe harms, finds a Japanese study published in the British Medical Journal. “Not fully reporting the harms of cancer drugs is of particular...
Original Article: Cancer drug trial studies urged to report harms transparently